Annals of Nuclear Medicine

Papers
(The TQCC of Annals of Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight55
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging35
Conversion from dose length product to effective dose for the CT component of whole-body PET/CT32
Clinical perspective on targeted alpha therapy using 225Ac24
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein24
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study23
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer’s disease patients21
A first-in-man PET study of 2-amino-[3-11C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers20
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?20
Vision-language model performance on the Japanese Nuclear Medicine Board Examination: high accuracy in text but challenges with image interpretation19
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study19
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions19
Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras18
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis18
A fully automatic deep learning-based method for segmenting regions of interest and predicting renal function in pediatric dynamic renal scintigraphy17
Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma17
Incidence of renal scarring on technetium-99 m dimercaptosuccinic acid renal scintigraphy after acute pyelonephritis, acute focal bacterial nephritis, and renal abscess17
Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy16
Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis16
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure16
Correction: Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson’s disease: a Bayesian approach15
PETFormer-SCL: a supervised contrastive learning-guided CNN–transformer hybrid network for Parkinsonism classification from FDG-PET14
Correction: Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images14
Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm14
Prognostic value of pre-treatment metabolic tumor volume on [S‑methyl‑11C]‑L‑methionine PET/CT in patients with local non-small cell lung carcinoma treated with single-fraction carbon-ion radiotherapy14
Diagnostic value of FDG PET/CT in determining the etiology of pericardial effusion13
Feasibility of whole-body 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography angiography using continuous bed motion in patients with vascular disease: a pilot study13
Effect of previous 177Lu-DOTATATE treatment on 90Y-microsphere treatment response in neuroendocrine tumor patients with liver metastasis13
Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer13
The value of 18F-FDG PET/CT in Langerhans cell histiocytosis13
Prediction of multivessel coronary artery disease and candidates for stress-only imaging using multivariable models with myocardial perfusion imaging13
Novel indices representing heterogeneous distributions of myocardial perfusion imaging13
Recent advancements in new tracers from first-in-human studies12
Comparison of transient and permanent LAD ligation in mice using 18F-FDG PET imaging12
Increased individual workload for nuclear medicine physicians over the past years: 2008–2023 data from The Netherlands12
Can interactive artificial intelligence be used for patient explanations of nuclear medicine examinations in Japanese?12
Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine12
Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor 11C-methionine PET/CT imaging11
Diagnostic value of 18F-FDG PET/CT in the follow-up of conjunctival melanoma11
Insights into lung cancer diagnosis and clinical management using [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT)11
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography10
Current status and perspectives of nuclear cardiology10
SPECT reconstruction using preprocessing masking for extra-cardiac uptake versus standard processing in 99mTc-sestamibi myocardial perfusion imaging10
Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study10
Brain imaging of sequential acquisition using a flexible PET scanner and 3-T MRI: quantitative and qualitative assessment10
Improvement in the estimation of perfusable tissue fraction and myocardial flow reserve in the ischemic myocardial lesions using ECG-gated dynamic myocardial PET with 15O-water10
Is there any effect of hcc location on selective internal radiation therapy with 90yttrium response?10
Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI10
[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor10
Correction: Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment uti10
Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital10
Multimodal imaging analysis of autosomal recessive Parkinson’s disease10
Correction to: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT images10
Booster administration of Tc-99m PMT for delayed static imaging in patients with biliary atresia9
A Monte Carlo study comparing dead-time losses of a gamma camera between tungsten functional paper and lead sheet for dosimetry in targeted radionuclide therapy with Lu-1779
Correction to: Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study9
Superiority of 68Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting9
Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by 99mTc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging9
Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoi9
Performance evaluation of dedicated brain PET scanner with motion correction system9
The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer9
Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis9
Detection of apoptosis by [18F]ML-10 after cardiac ischemia–reperfusion injury in mice9
Next day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc-labelled nanocolloid does not adversely affect long-term outcomes9
New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map9
Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands9
Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)8
Feasibility of position emission tomography derived endocardial wall strain: direct comparison with magnetic resonance using hybrid 13N ammonia PETMR system8
Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects8
Inferences of SPECT renal dynamic imaging injection quality based on lung and abdominal aorta imaging features8
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients8
Validation of advanced hybrid SPECT/CT system using dynamic anthropomorphic cardiac phantom8
Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?8
Investigation on low-iodine diet implementation by medical staff before radioactive iodine treatment for differentiated thyroid carcinoma7
Clinical value of 18F-FDG PET/CT in IgG4-related disease7
Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using 18F-FDG PET7
Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects7
Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer7
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma7
Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients7
18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment7
Blood and bone marrow dosimetry for thyroid cancer patients prepared with rhTSH injection7
Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan7
Comparative evaluation of radionuclide therapy using 90Y and 177Lu7
Response to the comment on the impact of anti-HER2 therapy on the accuracy of 68 Ga-HER2-affibody PET/CT imaging in metastatic breast cancer6
Application of artificial intelligence in brain molecular imaging6
Predictive value of 18F-FDG PET/CT-based radiomics model for lymph node metastasis in esophageal squamous cell carcinoma6
99mTc-labeled peptide targeting interleukin 13 receptor α 2 for tumor imaging in a cervical cancer mouse model6
Advances in the molecular imaging of primary aldosteronism6
Interobserver and intraobserver agreement for equivocal lesions in Ga-68 PSMA PET/CT according to PSMA-RADS 2.0 criteria6
Response to “Beyond glucose uptake: rethinking PET/CT and hematologic markers for immune profiling in early breast cancer”6
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy6
Development of lung cancer risk prediction models based on F-18 FDG PET images6
The quest for multifunctional and dedicated PET instrumentation with irregular geometries6
Differentiating second primary lung cancer from pulmonary metastasis in patients of single solitary pulmonary lesion with extrapulmonary tumor using multiparametric analysis of FDG PET/CT6
Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis6
New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT5
A review of harmonization strategies for quantitative PET5
Validation of quantitative [18F]NaF PET uptake parameters in bone diseases: a systematic review5
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients5
The role of dual-tracer PET imaging with ER and HER2 in patients with metastatic breast cancer: a pilot study5
Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment5
Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer5
Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound5
Toward standardization of tau PET imaging corresponding to various tau PET tracers: a multicenter phantom study5
AI screening of nuclear medicine safety breaches: patterns, causes, and opportunities for improved protocols: a systematic review5
Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis5
Predictive value of 18F-fluorodeoxyglucose uptake for axillary lymph node metastasis in operable breast cancer: impact of molecular subtypes5
Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study5
Pre-treatment 111In-pentetreotide SPECT/CT vs. baseline 177Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?5
Correlation between the thyroid computed tomography value and thyroid function in hyperthyroidism: a retrospective study5
Use of dose–volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres5
SPECT/CT imaging: quantifying 99mTc-MDP concentration in the spine and pelvis5
Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study5
Pharmacokinetics and dosimetry of [177Lu]Lu-PSMA-617 and [68Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPC5
Advances in positron emission tomography tracers related to vascular calcification5
Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer5
Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment5
Radiolabeled florescent-magnetic graphene oxide nanosheets: probing the biodistribution of a potential PET-MRI hybrid imaging agent for detection of fibrosarcoma tumor5
0.16314911842346